The meeting we were planning on attending tomorrow at Invitrogen’s Carlsbadistan headquarters has been postponed until October 28 thanks to some amendments to their Applied Biosystems buyout agreement. The company wants to give shareholders more time to consider the deal.
Phew. There are a few details of the $6.4 billion buyout that we wanted to study up on. (Just kidding.)
[Link: Forbes.com]
RSS Feed-Posts
{ 0 comments… add one now }